Company description
C3i is a one-stop shop in the development chain of cell & gene therapy. We are a CDMO that is partner-focused and patient-driven. We offer cost-effective CGT manufacturing services from process development to phase III for the US, EU, and Canada with commercial manufacturing in 2024. All without needing technology transfer to multiple sites. Our vision is to be a leading CDMO that provides life-saving cell & gene therapies available to everyone who needs it. Our mission is to develop and manufacture cost-effective state-of-the-art cell and gene therapies making it accessible to people in need.
